ENDOLOGIX INC - NOTE 3.250%11/0

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Debt / NOTE 3.250%11/0
Number of holders
16
Total 13F principal, excl. options
125,392,000
Principal change
-800,000
Total reported value, excl. options
$166,421,000
Value change
-$1,057,429
Number of buys
8
Number of sells
-3
Price
$1.32

Significant Holders of ENDOLOGIX INC - NOTE 3.250%11/0 as of Q3 2016

18 filings reported holding 29266SAB2 - ENDOLOGIX INC - NOTE 3.250%11/0 as of Q3 2016.
ENDOLOGIX INC - NOTE 3.250%11/0 has 16 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of $125,392,000 of principal .
Largest 10 bondholders include CITADEL ADVISORS LLC ($27,800,000 of principal), HIGHBRIDGE CAPITAL MANAGEMENT LLC ($26,005,000 of principal), Polygon Management Ltd. ($17,450,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($16,900,000 of principal), LINDEN ADVISORS LP ($9,319,000 of principal), Context Capital Management, LLC ($6,075,000 of principal), PIONEER INVESTMENT MANAGEMENT INC ($6,000,000 of principal), SSI INVESTMENT MANAGEMENT INC ($4,626,000 of principal), BANK OF AMERICA CORP /DE/ ($2,600,000 of principal), and Nicholas Investment Partners, LP ($2,250,000 of principal).
This table shows the top 16 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.